High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial

Leuk Lymphoma. 2014 May;55(5):1206-8. doi: 10.3109/10428194.2013.825906. Epub 2013 Aug 28.

Authors

Anna Laurell¹, Arne Kolstad, Mats Jerkeman, Riikka Räty, Christian H Geisler

Affiliation

¹ Department of Radiology, Oncology and Radiation Science, Uppsala University , Uppsala , Sweden.

PMID: 23876100
DOI: 10.3109/10428194.2013.825906

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Murine-Derived / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cytarabine / administration & dosage
Humans
Lymphoma, Mantle-Cell / drug therapy*
Lymphoma, Mantle-Cell / pathology*
Rituximab
Treatment Failure
Treatment Outcome

Substances

Antibodies, Monoclonal, Murine-Derived
Cytarabine
Rituximab